Press release
Rise In Bleeding Disorders Driving The Growth Of The Market Due To Improved Diagnosis And Awareness: A Key Driver Powering Von Willebrand Disease Market Growth In 2025
Von Willebrand Disease
What Is the Current Von Willebrand Disease Market Size and Its Estimated Growth Rate?
The von willebrand disease market size has grown strongly in recent years. It will grow from $1.74 billion in 2024 to $1.88 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing awareness about rare bleeding disorders, rising diagnosis rates of von willebrand disease, growth in research funding for blood disorders, increasing access to healthcare, and rising use of prophylactic treatments in hemophilia care.
Robust expansion is anticipated in the von Willebrand disease market in the coming years, with predictions suggesting it will reach a value of $2.48 billion in 2029, reflecting a compound annual growth rate (CAGR) of 7.2%. The predicted rise in the forecast period can be linked to factors such as the progressive development of gene therapy for the treatment of bleeding disorders, escalating investment in biotech research, an increased demand for non-invasive diagnostic methods, the growing application of digital health technology for disease assessment, and the expansion of telemedicine services for rare conditions. The forecast period is also expected to see major trends including advancements in gene therapy strategies, the utilisation of artificial intelligence in diagnostics, innovative non-invasive diagnostic tools, the launch of new drug delivery mechanisms, and the use of digital health platforms for patient education.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22168
How Are Emerging Segments Shaping the Von Willebrand Disease Market Landscape?
The von willebrand disease market covered in this report is segmented -
1) By Type: Type 1, Type 2, Type 3
2) By Drugs: Antihemophilic Factor, Coagulation Factor VIII Complex, Von Willebrand Factor, Desmopressin Acetate, Other Drugs
3) By Severity: Mild, Moderate, Severe
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End Users: Hospitals, Speciality Clinics, Homecare, Other End Users
Subsegmentss:
1) By Type 1: Mild Von Willebrand Disease, Moderate Von Willebrand Disease, Severe Von Willebrand Disease
2) By Type 2: Type 2A, Type 2B, Type 2M, Type 2N
3) By Type 3: Congenital Type 3, Acquired Type 3
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22168&type=smp
Which Growth Factors Are Influencing Von Willebrand Disease Market Expansion?
The escalation in the occurrence of bleeding disorders is anticipated to fuel the expansion of the von Willebrand disease market in the future. Bleeding disorders, a collection of medical conditions, impair the body's clotting capacity, leading to prolonged or excessive bleeding. The surge in identified bleeding disorders can be mainly attributed to progressions in medical awareness and diagnostic techniques, enabling physicians and healthcare institutions to accurately recognize cases that would have otherwise remained undetected. Treatment for von Willebrand disease aids those with bleeding disorders by enhancing blood clotting, reducing excessive bleeding, and thus, augmenting their overall quality of life. For instance, the United Kingdom Haemophilia Centre Doctors' Organization, a UK-based medical institution, reported in November 2022 that the number of Hemophilia A new registrations in the UK increased from 16 in 2021 to 19 in 2022. As a result, the increasing prevalence of bleeding disorders is fuelling the expansion of the von Willebrand disease market.
Who Are the Dominant Players Across Different Von Willebrand Disease Market Segments?
Major companies operating in the von willebrand disease market are Pfizer Inc., Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Mayo Clinic, CSL Behring (a subsidiary of CSL Limited), Cleveland Clinic, Grifols S.A., Kedrion Biopharma Inc., Shanghai RAAS Blood Products Co. Ltd., Biotest AG, Versiti Inc., Fortis Healthcare Limited, LFB S.A., Hualan Biological Engineering Inc., Bio Products Laboratory Ltd. (BPL), Octapharma AG, Sino Biological Inc., Reliance Life Sciences Pvt. Ltd.
What Are the Latest Developing Trends in the Von Willebrand Disease Market?
Leading companies in the von willebrand disease market are turning their attention to innovative therapies such as von willebrand factor concentrate for increased treatment performance, minimizing bleeding occurrences, and bettering patient outcomes. Von willebrand factor (VWF) concentrate, a medication designed to manage and avert bleeding in those with von willebrand disease (VWD), a hereditary bleeding disorder prompted by a shortage or malfunction of the von willebrand factor. For example, in April 2024, Octapharma USA Inc., a pharmaceutical firm based in the US, publicized the FDA approval of Wilate. This product is a VWF concentrate involving a lyophilized powder solution for intravenous injection, intended for regular prophylaxis to lessen the frequency of bleeding incidents in adults and children aged 6 and above. The FDA's orphan drug designation awards Wilate with up to seven years of market monopoly, a strategy designed to foster treatment innovations for rare ailments.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/von-willebrand-disease-global-market-report
Which Geographic Regions Are Expected to Dominate the Von Willebrand Disease Market in the Coming Years?
North America was the largest region in the von willebrand disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the von willebrand disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Von Willebrand Disease Market?
2. What is the CAGR expected in the Von Willebrand Disease Market?
3. What Are the Key Innovations Transforming the Von Willebrand Disease Industry?
4. Which Region Is Leading the Von Willebrand Disease Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rise In Bleeding Disorders Driving The Growth Of The Market Due To Improved Diagnosis And Awareness: A Key Driver Powering Von Willebrand Disease Market Growth In 2025 here
News-ID: 4073816 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Willebrand
Von Willebrand Disease (VWD) Market Growth, Trends, Consumer Demand and Key Oppo …
Introduction
Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, affecting both men and women across all age groups. The disease results from either a deficiency or dysfunction of von Willebrand factor (VWF), a key protein that enables platelets to adhere to damaged blood vessels and plays a vital role in clot formation. Symptoms vary widely, from mild nosebleeds and heavy menstrual cycles to severe bleeding episodes that can…
Von Willebrand Disease Treatment Market Statistical Forecast, Trade Analysis 202 …
DataM Intelligence has published a new research report on "Von Willebrand Disease Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research…
Von Willebrand Disease Treatment Market Size 2024 to 2031.
Market Overview and Report Coverage
Von Willebrand Disease is a rare inherited bleeding disorder that affects the blood's ability to clot properly. The Von Willebrand Disease Treatment Market encompasses medications, blood transfusions, and other therapies aimed at managing the symptoms and improving the quality of life for patients with this condition.
The future outlook for the Von Willebrand Disease Treatment Market is promising, with a projected growth at a CAGR…
Acquired von Willebrand Disease (AvWD) Treatment Market Size, Analysis And Forec …
Acquired von Willebrand syndrome is a highly heterogeneous bleeding disorder, that usually displays mild to moderate hemorrhagic symptoms that may at times be severe too. Many a time the severity increases post-surgery. AvWS is considered a rare disorder, however, the actual prevalence is not as rare. In case the laboratory findings diagnose vWD in a patient with no family history, AvWS-associated conditions are usually explored. The acquired von Willebrand disease…
Norway Von Willebrand Disease Treatment Market Trends, Current Demand, and Busin …
According to a Transparency Market Research (TMR) research report, the global von willebrand disease treatment market is expected to reach ~US$ 900 Mn by the end of 2030. This suggests that the market is likely to expand at a CAGR of ~6% during the forecast period, 2020 to 2030.
The business intelligence study on the market is prepared by employing industry-validated primary and secondary methods. The study uses these to collect…
Von Willebrand disease treatment therapies and Von Willebrand Disease treatment …
The research report presents a comprehensive assessment of the Von Willebrand Disease Treatment Market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application and industry
To remain ‘ahead’ of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=1496
Von Willebrand Disease…
